Natural Beauty Bio-Technology Dividends and Buybacks
Dividend criteria checks 0/6
Natural Beauty Bio-Technology does not currently pay a dividend.
Key information
0%
Dividend yield
n/a
Buyback Yield
| Total Shareholder Yield | n/a |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | HK$0.003 |
| Payout ratio | 0% |
Recent dividend and buyback updates
Recent updates
Natural Beauty Bio-Technology Limited's (HKG:157) Shareholders Might Be Looking For Exit
Jul 25
Natural Beauty Bio-Technology Limited's (HKG:157) Share Price Could Signal Some Risk
Jun 07Some Investors May Be Worried About Natural Beauty Bio-Technology's (HKG:157) Returns On Capital
Feb 24Some Investors May Be Worried About Natural Beauty Bio-Technology's (HKG:157) Returns On Capital
Oct 03Investors Could Be Concerned With Natural Beauty Bio-Technology's (HKG:157) Returns On Capital
Mar 09The Returns On Capital At Natural Beauty Bio-Technology (HKG:157) Don't Inspire Confidence
Nov 09Natural Beauty Bio-Technology (HKG:157) Has Some Difficulty Using Its Capital Effectively
Jun 12Is Natural Beauty Bio-Technology (HKG:157) Using Capital Effectively?
Feb 16
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if 157's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 157's dividend payments have been increasing.
Dividend Yield vs Market
| Natural Beauty Bio-Technology Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (157) | 0% |
| Market Bottom 25% (HK) | 3.4% |
| Market Top 25% (HK) | 8.1% |
| Industry Average (Personal Products) | 3.7% |
| Analyst forecast (157) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate 157's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 157's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: 157 is not paying a notable dividend for the Hong Kong market.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as 157 has not reported any payouts.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/11 09:41 |
| End of Day Share Price | 2025/01/10 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Natural Beauty Bio-Technology Limited is covered by 7 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Paul Quah | CLSA |
| Holly Hou | Everbright Securities International (HK) Limited (“EBSIHK”) |
| ICEA Research Team | ICEA Research |